UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 27, 2004
Commission file number 000-49602
SYNAPTICS INCORPORATED
| Delaware | 77-0118518 | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
2381 Bering Drive
San Jose, California 95131
(408) 434-0110
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes x No o
Number of shares of Common Stock outstanding at May 4, 2004: 24,834,789
SYNAPTICS INCORPORATED
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2004
TABLE OF CONTENTS
PART I FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)
(unaudited)
| March 31, | June 30, | |||||||
| 2004 |
2003 |
|||||||
ASSETS |
||||||||
Current Assets: |
||||||||
Cash and cash equivalents |
$ | 55,494 | $ | 41,697 | ||||
Short-term investments |
35,291 | 35,589 | ||||||
Restricted cash |
240 | 240 | ||||||
Accounts receivable, net of allowances of $130 and $160,
respectively |
18,808 | 13,181 | ||||||
Inventories |
5,477 | 6,428 | ||||||
Prepaid expenses and other current assets |
2,779 | 2,637 | ||||||
Total current assets |
118,089 | 99,772 | ||||||
Property and equipment, net |
1,976 | 1,934 | ||||||
Goodwill |
1,891 | 1,968 | ||||||
Other assets |
937 | 834 | ||||||
| $ | 122,893 | $ | 104,508 | |||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
8,300 | 6,893 | ||||||
Accrued compensation |
3,632 | 2,808 | ||||||
Accrued warranty |
891 | 1,002 | ||||||
Income taxes payable |
4,788 | 1,661 | ||||||
Other accrued liabilities |
2,638 | 3,362 | ||||||
Capital leases and equipment financing obligations |
55 | 231 | ||||||
Total current liabilities |
20,304 | 15,957 | ||||||
Capital leases and equipment financing obligations, net of current
portion |
| 28 | ||||||
Note payable to a related party |
1,500 | 1,500 | ||||||
Other liabilities |
843 | 759 | ||||||
Stockholders equity: |
||||||||
Common stock;
$0.001 par value; 60,000,000 shares authorized; 24,814,164
and 23,835,877 shares issued and outstanding, respectively |
25 | 24 | ||||||
Additional paid-in capital |
83,111 | 78,761 | ||||||
Deferred stock compensation |
(760 | ) | (1,184 | ) | ||||
Notes receivable from stockholders |
| (20 | ) | |||||
Accumulated other comprehensive income |
14 | 100 | ||||||
Retained earnings |
17,856 | 8,583 | ||||||
Total stockholders equity |
100,246 | 86,264 | ||||||
| $ | 122,893 | $ | 104,508 | |||||
See notes to consolidated financial statements.
3
SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share data)
(unaudited)
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 31, |
March 31, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Net revenue |
$ | 34,284 | $ | 26,103 | $ | 98,129 | $ | 72,479 | ||||||||
Cost of revenue (1) |
19,726 | 15,385 | 57,286 | 41,745 | ||||||||||||
Gross margin |
14,558 | 10,718 | 40,843 | 30,734 | ||||||||||||
Operating expenses: |
||||||||||||||||
Research and development (1) |
5,613 | 4,942 | 15,839 | 15,077 | ||||||||||||
Selling, general, and administrative (1) |
3,452 | 2,715 | 9,819 | 7,957 | ||||||||||||
Amortization of other acquired intangible assets |
| | | 40 | ||||||||||||
Amortization of deferred stock compensation |
128 | 137 | 397 | 363 | ||||||||||||
Restructuring |
| | 432 | | ||||||||||||
Total operating expenses |
9,193 | 7,794 | 26,487 | 23,437 | ||||||||||||
Income from operations |
5,365 | 2,924 | 14,356 | 7,297 | ||||||||||||
Interest and other income, net |
246 | 259 | 701 | 815 | ||||||||||||
Interest expense |
(33 | ) | (35 | ) | (101 | ) | (121 | ) | ||||||||
Income before provision for income taxes |
5,578 | 3,148 | 14,956 | 7,991 | ||||||||||||
Provision for income taxes |
2,073 | 1,079 | 5,683 | 2,877 | ||||||||||||
Net income |
$ | 3,505 | $ | 2,069 | $ | 9,273 | $ | 5,114 | ||||||||
Net income per share: |
||||||||||||||||
Basic |
$ | 0.14 | $ | 0.09 | $ | 0.38 | $ | 0.22 | ||||||||
Diluted |
$ | 0.13 | $ | 0.08 | $ | 0.34 | $ | 0.21 | ||||||||
Shares used in computing net income per share: |
||||||||||||||||
Basic |
24,671,358 | 23,537,666 | 24,266,653 | 23,407,637 | ||||||||||||
Diluted |
27,451,066 | 25,125,131 | 26,921,070 | 24,869,050 | ||||||||||||
| (1) | Cost of revenue excludes $5,000, $7,000, $15,000, and $21,000 of amortization of deferred stock compensation for the three months ended March 31, 2004 and 2003, and the nine months ended March 31, 2004 and 2003, respectively. Research and development expense excludes $21,000, $38,000, $76,000, and $115,000 of amortization of deferred stock compensation for the three months ended March 31, 2004 and 2003, and the nine months ended March 31, 2004 and 2003, respectively. Selling, general, and administrative expenses exclude $102,000, $92,000, $306,000, and $227,000 of amortization of deferred stock compensation for the three months ended March 31, 2004 and 2003, and the nine months ended March 31, 2004 and 2003, respectively. These amounts have been aggregated and reflected as Amortization of deferred stock compensation. |
See notes to consolidated financial statements.
4
SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
| Nine Months Ended | ||||||||
| March 31, |
||||||||
| 2004 |
2003 |
|||||||
Cash flows from operating activities |
||||||||
Net income |
$ | 9,273 | $ | 5,114 | ||||
Adjustments to reconcile net income to net cash provided by
operating activities: |
||||||||
Depreciation of property and equipment |
786 | 1,071 | ||||||
Amortization of other acquired intangible assets |
| 40 | ||||||
Amortization of deferred stock compensation |
397 | 363 | ||||||
Fair value of options issued to consultants for services rendered |
| 17 | ||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(5,627 | ) | (910 | ) | ||||
Inventories |
951 | 85 | ||||||
Prepaid expenses and other current assets |
(142 | ) | (781 | ) | ||||
Other assets |
(103 | ) | 10 | |||||
Accounts payable |
1,407 | 939 | ||||||
Accrued compensation |
824 | 222 | ||||||
Accrued warranty |
(111 | ) | | |||||
Income taxes payable |
3,127 | 404 | ||||||
Other accrued liabilities |
(648 | ) | 529 | |||||
Other liabilities |
84 | 57 | ||||||
Net cash provided by operating activities |
10,218 | 7,160 | ||||||
Cash flows from investing activities |
||||||||
Purchases of short-term investments |
(17,336 | ) | (18,144 | ) | ||||
Proceeds from sales and maturities of short-term investments |
17,548 | 3,569 | ||||||
Purchase of property and equipment |
(828 | ) | (898 | ) | ||||
Net cash used in investing activities |
(616 | ) | (15,473 | ) | ||||
Cash flows from financing activities |
||||||||
Payments on capital leases and equipment financing obligations |
(204 | ) | (363 | ) | ||||
Proceeds from issuance of common stock upon exercise of options
and stock purchase plan |
4,379 | 1,648 | ||||||
Repayment of notes receivable from stockholders |
20 | 121 | ||||||
Net cash provided by financing activities |
4,195 | 1,406 | ||||||
Net increase (decrease) in cash and cash equivalents |
13,797 | (6,907 | ) | |||||
Cash and cash equivalents at beginning of period |
41,697 | 45,491 | ||||||
Cash and cash equivalents at end of period |
$ | 55,494 | $ | 38,584 | ||||
Supplemental disclosures of cash flow information |
||||||||
Cash paid for interest |
$ | 5 | $ | 22 | ||||
Cash paid for income taxes |
2,550 | 2,442 | ||||||
See notes to consolidated financial statements
5
SYNAPTICS INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1. Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and generally accepted accounting principles. However, certain information or footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In our opinion, the statements include all adjustments, which are of a normal and recurring nature, necessary for the fair presentation of the results of the interim periods presented. The results of operations for the interim periods are not necessarily indicative of the operating results for the full fiscal year or any future period. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our annual report on Form 10-K for the year ended June 30, 2003.
The consolidated financial statements include our financial statements and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
On an on-going basis, we evaluate our estimates, including those related to revenue recognition, allowances for doubtful accounts, inventory, product warranties, and income taxes. These estimates are based on historical facts and various other assumptions we believe to be reasonable at the time the estimates are made.
Our fiscal year ends on the last Saturday in June. For ease of presentation, the accompanying consolidated financial statements have been shown as ending on June 30 and calendar quarter ends for all annual, interim, and quarterly financial statement captions.
We have elected to follow APB Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations in accounting for stock options. Had compensation expense for stock options been determined based on the fair value of the option at date of grant consistent with the provisions of Statement of Financial Accounting Standard No. 123, Accounting for Stock-Based Compensation, net income and earnings per share would have been reduced to the pro forma amounts indicated below (in thousands, except per share amounts):
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 31, |
March 31, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Net income as reported |
$ | 3,505 | $ | 2,069 | $ | 9,273 | $ | 5,114 | ||||||||
Add: Total stock-based employee compensation included
in reported net income, net of related tax |
79 | 137 | 244 | 363 | ||||||||||||
Deduct: Total stock-based employee compensation
determined under fair value based method for all
awards, net of related tax |
(1,156 | ) | (778 | ) | (3,017 | ) | (2,018 | ) | ||||||||
Net income pro forma |
$ | 2,428 | $ | 1,428 | $ | 6,500 | $ | 3,459 | ||||||||
Net income per share Basic: |
||||||||||||||||
As reported |
$ | 0.14 | $ | 0.09 | $ | 0.38 | $ | 0.22 | ||||||||
Pro forma |
$ | 0.10 | $ | 0.06 | $ | 0.27 | $ | 0.15 | ||||||||
Net income per share Diluted: |
||||||||||||||||
As reported |
$ | 0.13 | $ | 0.08 | $ | 0.34 | $ | 0.21 | ||||||||
Pro forma |
$ | 0.09 | $ | 0.06 | $ | 0.24 | $ | 0.14 | ||||||||
The fair value of each award granted was estimated at the date of grant using a Black-Scholes option-pricing model, assuming no expected dividends and the following weighted average assumptions:
6
| Employee Stock | ||||||||||||||||
| Stock Options |
Purchase Plan |
|||||||||||||||
| Three Months Ended | Three Months Ended | |||||||||||||||
| March 31, |
March 31, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Expected volatility |
79.1 | % | 84.5 | % | 68.2 | % | 84.5 | % | ||||||||
Expected life in years |
5 | 5 | 0.4 | 0.4 | ||||||||||||
Risk-free interest rate |
2.8 | % | 2.8 | % | 1.0 | % | 1.1 | % | ||||||||
Weighted average fair value |
$ | 10.38 | $ | 4.90 | $ | 2.65 | $ | 2.73 | ||||||||
| Employee Stock | ||||||||||||||||
| Stock Options |
Purchase Plan |
|||||||||||||||
| Nine Months Ended | Nine Months Ended | |||||||||||||||
| March 31, |
March 31, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Expected volatility |
71.6 | % | 84.5 | % | 65.0 | % | 84.5 | % | ||||||||
Expected life in years |
5 | 5 | 0.4 | 0.4 | ||||||||||||
Risk-free interest rate |
2.8 | % | 2.8 | % | 1.0 | % | 1.1 | % | ||||||||
Weighted average fair value |
$ | 8.00 | $ | 4.21 | $ | 2.57 | $ | 2.86 | ||||||||
2. Revenue Recognition
We recognize revenue from product sales when there is persuasive evidence that an arrangement exists, delivery has occurred and title has transferred, the price is fixed and determinable, and collectibility is reasonably assured. We accrue for estimated sales returns and other allowances at the time we recognize revenue, which is typically upon shipment, based on historical experience. Contract revenue for research and development is recorded as earned based on the performance requirements of the contract. Non-refundable contract fees for which no further performance obligations exist, and for which there is no continuing involvement by us, are recognized on the earlier of when the payments are received or when collection is assured.
3. Net Income Per Share
Basic net income per share amounts have been computed using the weighted average number of shares of common stock outstanding during each period. Diluted net income per share amounts also include the effect of potentially dilutive securities, including stock options, when dilutive.
The following table presents the computation of basic and diluted net income per share (in thousands, except per share amounts):
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 31, |
March 31, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Numerator for basic and diluted net income per share: |
||||||||||||||||
Net income |
$ | 3,505 | $ | 2,069 | $ | 9,273 | $ | 5,114 | ||||||||
Denominator for basic net income per share: |
||||||||||||||||
Weighted average common shares outsanding |
24,671 | 23,537 | 24,267 | 23,407 | ||||||||||||
Denominator for basic net income per share |
24,671 | 23,537 | 24,267 | 23,407 | ||||||||||||
Denominator for diluted net income per share: |
||||||||||||||||
Shares used above, basic |
24,671 | 23,537 | 24,267 | 23,407 | ||||||||||||
Effect of dilutive stock options |
2,780 | 1,588 | 2,654 | 1,462 | ||||||||||||
Denominator for diluted net income per share |
27,451 | 25,125 | 26,921 | 24,869 | ||||||||||||
Net income per share: |
||||||||||||||||
Basic |
$ | 0.14 | $ | 0.09 | $ | 0.38 | $ | 0.22 | ||||||||
Diluted |
$ | 0.13 | $ | 0.08 | $ | 0.34 | $ | 0.21 | ||||||||
7
Options to purchase 19,000, 1,415,923, 125,720, and 1,286,224 shares of common stock that were outstanding during the three months ended March 31, 2004 and 2003, and the nine months ended March 31, 2004 and 2003, respectively, were not included in the computation of diluted earnings per share for these periods because the options exercise prices were greater than the average market price of our common stock during these periods, and therefore, their effect would have been antidilutive.
4. Cash Equivalents and Short-term Investments
Cash equivalents consist of highly liquid investments with original maturities of three months or less. Short-term investments consist of marketable securities and are classified as securities available for sale under Statement of Financial Accounting Standards No. 115, Accounting for Certain Investments in Debt and Equity Securities. Such securities are reported at fair value, with unrealized gains and losses, net of taxes, excluded from earnings and shown separately as a component of accumulated other comprehensive income within stockholders equity. Interest earned on marketable securities is included in interest income. Realized gains and losses on the sale of marketable securities are determined using the specific identification method.
5. Restructuring
In late June 2003, we completed the acquisition of NSM Technology Limited (NSM), a Hong Kong company. In conjunction with the acquisition of NSM, duplicate operational positions were identified at our San Jose and Taiwan locations. During the three months ended September 30, 2003, we recorded $432,000 related to the elimination of those positions as restructuring charges. There were no restructuring charges for the three months ended March 31, 2004 and 2003 and the nine months ended March 31, 2003. The restructuring expenses consisted primarily of severance costs for the terminated employees who were notified in early July 2003.
6. Inventories
Inventories are stated at the lower of cost (first-in, first-out method) or market (estimated net realizable value) and consisted of the following (in thousands):
| March 31, | June 30, | |||||||
| 2004 |
2003 |
|||||||
Raw materials |
$ | 5,205 | $ | 6,062 | ||||
Finished goods |
272 | 366 | ||||||
| $ | 5,477 | $ | 6,428 | |||||
Write-downs to reduce the carrying value of obsolete, slow moving, and non-usable inventory to its net realizable value are charged to cost of revenue.
7. Goodwill
The carrying amount of goodwill was as follows (in thousands):
| March 31, | June 30, | |||||||
| 2004 |
2003 |
|||||||
NSM acquisition |
$ | 1,125 | $ | 1,202 | ||||
ASL acquisition |
766 | 766 | ||||||
| $ | 1,891 | $ | 1,968 | |||||
8. Product Warranties and Indemnifications
We generally warrant our products for a period of 12 to 37 months from the date of sale and estimate probable product warranty costs at the time revenue is recognized. Factors that affect our warranty liability include historical and anticipated rates of warranty claims, material usage, and service delivery costs. We assess the adequacy of our warranty obligations periodically and adjust the accrued warranty liability on the basis of our estimates.
8
Changes in our warranty liability for the nine-month periods ended March 31, 2004 and 2003 were as follows (in thousands):
| Nine Months Ended | ||||||||
| March 31, |
||||||||
| 2004 |
2003 |
|||||||
Beginning accrued warranty |
$ | 1,002 | $ | 1,002 | ||||
Provision for product warranties |
384 | 37 | ||||||
Cost of warranty claims |
(495 | ) | (37 | ) | ||||
Ending accrued warranty |
$ | 891 | $ | 1,002 | ||||
In connection with certain third-party agreements we have executed in the past, we are obligated to indemnify the third party in connection with any technology infringement by us. Maximum potential future payments cannot be estimated because these agreements do not have a maximum stated liability. However, historical costs related to these indemnification provisions have not been significant. We have not recorded any liability in our consolidated financial statements for such indemnification.
9. Income Taxes
The income tax provision for the nine-month periods ended March 31, 2004 and 2003 reflects an effective income tax rate based on expected pre-tax income for the year partially offset by a research and development tax credit. The effective tax rates for the nine months ended March 31, 2004 and 2003 were approximately 38.0% and 36.0%, respectively, and represent a lower percentage than the combined federal and state statutory rate primarily due to the benefit of research and development tax credits and tax exempt interest income.
10. Segment, Customers, and Geographic Information
We operate in one segment, the development, marketing, and sale of interactive user interface solutions for intelligent electronic devices and products, and currently generate our revenue primarily from companies in the personal computer (PC) market.
The following is a summary of operations within geographic areas based on the customer location (in thousands):
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 31, |
March 31, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Revenue from sales to unaffiliated
customers: |
||||||||||||||||
China |
$ | 20,629 | $ | 11,588 | $ | 52,457 | $ | 41,947 | ||||||||
Taiwan |
8,085 | 8,296 | 29,834 | 16,112 | ||||||||||||
Other |
5,570 | 6,219 | 15,838 | 14,420 | ||||||||||||
| $ | 34,284 | $ | 26,103 | $ | 98,129 | $ | 72,479 | |||||||||
Major customer data as a percentage of total revenue:
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 31, |
March 31, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Customer A |
31 | % | 12 | % | 24 | % | 11 | % | ||||||||
Customer B |
* | * | 10 | % | * | |||||||||||
Major customer data as a percentage of total accounts receivable:
| March 31, | June 30, | ||||||||
| 2004 |
2003 |
||||||||
Customer A |
35 | % | 26 | % | |||||
| * | Less than 10% |
9